As a diagnostic marker, a loss of Bcl-2 immunohistochemical expression was not significantly associated with a diagnosis of uLMS vs leiomyoma variants and STUMP, with an OR of 2.981 (95% CI 0.143–61.979; p = 0.48) (Fig. 1). The gene discussed is BCL2; the disease is leiomyoma.